Secukinumab versus conventional immunotherapy in myasthenia gravis: A single-Center 24-week retrospective comparative study

International Immunopharmacology 2026

View at publisher
Authors: Shuangmei Zhang, Anrong Wang, Xiaodong Song, Zhaoxu Zhang
DOI: 10.1016/j.intimp.2026.116175
Cited by: 1
References: 31

Fields of Study & Subjects

Myasthenia Gravis and Thymoma Psoriasis: Treatment and Pathogenesis Autoimmune Bullous Skin Diseases

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
172
Pages
116175–116175
Publication date
16 January 2026
Language
EN